Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Optimal use of LLT after ACS

Optimal use of LLT after ACS

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

LDL-C in the management of high cardiovascular risk, changing the paradigm for prevention

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

The Lixilan-L Study

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis on management and pattern of PCSK9 inhibitor use in the first six months of treatment

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis for PCSK9 inhibitors new users

Italian real-world analysis for PCSK9 inhibitors new users